These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 16467878

  • 1. uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line.
    Yoon SY, Lee YJ, Seo JH, Sung HJ, Park KH, Choi IK, Kim SJ, Oh SC, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS.
    Cell Res; 2006 Jan; 16(1):75-81. PubMed ID: 16467878
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 3. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr 20; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 4. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
    Bessard A, Frémin C, Ezan F, Coutant A, Baffet G.
    J Cell Physiol; 2007 Aug 20; 212(2):526-36. PubMed ID: 17427199
    [Abstract] [Full Text] [Related]

  • 5. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A, Xue M, Jackson C, Smith RC.
    Int J Biochem Cell Biol; 2009 Aug 20; 41(8-9):1731-8. PubMed ID: 19433314
    [Abstract] [Full Text] [Related]

  • 6. Inducible nitric oxide synthase-nitric oxide plays an important role in acute and severe hypoxic injury to pancreatic beta cells.
    Ko SH, Ryu GR, Kim S, Ahn YB, Yoon KH, Kaneto H, Ha H, Kim YS, Song KH.
    Transplantation; 2008 Feb 15; 85(3):323-30. PubMed ID: 18301327
    [Abstract] [Full Text] [Related]

  • 7. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells.
    Kim MH, Cho HS, Jung M, Hong MH, Lee SK, Shin BA, Ahn BW, Jung YD.
    Int J Oncol; 2005 Jun 15; 26(6):1669-74. PubMed ID: 15870884
    [Abstract] [Full Text] [Related]

  • 8. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
    Zhang G, Cai X, López-Guisa JM, Collins SJ, Eddy AA.
    J Am Soc Nephrol; 2004 Aug 15; 15(8):2090-102. PubMed ID: 15284295
    [Abstract] [Full Text] [Related]

  • 9. Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression.
    Serratì S, Margheri F, Fibbi G, Di Cara G, Minafra L, Pucci-Minafra I, Liotta F, Annunziato F, Pucci M, Del Rosso M.
    J Pathol; 2008 Apr 15; 214(5):545-54. PubMed ID: 18189329
    [Abstract] [Full Text] [Related]

  • 10. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells.
    Oh JH, Lee TJ, Park JW, Kwon TK.
    Eur J Pharmacol; 2008 Dec 03; 599(1-3):11-7. PubMed ID: 18838070
    [Abstract] [Full Text] [Related]

  • 11. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
    Ahmed KM, Dong S, Fan M, Li JJ.
    Mol Cancer Res; 2006 Dec 03; 4(12):945-55. PubMed ID: 17189385
    [Abstract] [Full Text] [Related]

  • 12. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
    Hagiwara H, Sato H, Shirai S, Kobayashi S, Fukumoto K, Ishida T, Seki T, Ariga T, Yano T.
    Life Sci; 2006 Apr 04; 78(19):2249-54. PubMed ID: 16289236
    [Abstract] [Full Text] [Related]

  • 13. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 04; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 14. Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide.
    Thomas DD, Espey MG, Ridnour LA, Hofseth LJ, Mancardi D, Harris CC, Wink DA.
    Proc Natl Acad Sci U S A; 2004 Jun 15; 101(24):8894-9. PubMed ID: 15178764
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Besch R, Berking C, Kammerbauer C, Degitz K.
    Cell Death Differ; 2007 Apr 15; 14(4):818-29. PubMed ID: 17110957
    [Abstract] [Full Text] [Related]

  • 16. Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways.
    Jung WK, Choi I, Lee DY, Yea SS, Choi YH, Kim MM, Park SG, Seo SK, Lee SW, Lee CM, Park YM, Choi IW.
    Int J Biochem Cell Biol; 2008 Apr 15; 40(11):2572-82. PubMed ID: 18571461
    [Abstract] [Full Text] [Related]

  • 17. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
    Baek MK, Kim MH, Jang HJ, Park JS, Chung IJ, Shin BA, Ahn BW, Jung YD.
    Oncol Rep; 2008 Dec 15; 20(6):1569-75. PubMed ID: 19020743
    [Abstract] [Full Text] [Related]

  • 18. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
    Sprague LD, Tomaso H, Mengele K, Schilling D, Bayer C, Stadler P, Schmitt M, Molls M.
    Oncol Rep; 2007 May 15; 17(5):1259-68. PubMed ID: 17390074
    [Abstract] [Full Text] [Related]

  • 19. Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells.
    Shen J, Lee W, Li Y, Lau CF, Ng KM, Fung ML, Liu KJ.
    J Neurochem; 2008 Oct 15; 107(2):478-87. PubMed ID: 18717816
    [Abstract] [Full Text] [Related]

  • 20. Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells.
    Ma Z, Webb DJ, Jo M, Gonias SL.
    J Cell Sci; 2001 Sep 15; 114(Pt 18):3387-96. PubMed ID: 11591826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.